Research team awarded $1.2 million to research cancer that impacts youth

April 22, 2014

A team of researchers that includes Drs. Michael Rudnicki, Jeff Dilworth, Lynn Megeney and Theodore Perkins have been awarded $1.2 million by the Canadian Institutes of Health Research (CIHR) for a five-year study into the triggers that cause Alveolar Rhabdomyosarcoma (aRMS), an aggressive cancer that develops in children and teenagers. With a view to developing new treatments for aRMS, the research team plans to study the underlying genomic factors that cause the cancer to develop. Specifically, the team will investigate the hypothesis that RMS tumour formation is initiated by cancerous muscle stem cells. Further details, including a list of co-investigators, can be found in CIHR’s Funding Decision Database.

About the Ottawa Hospital Research Institute
The Ottawa Hospital Research Institute (OHRI) is the research arm of The Ottawa Hospital and is an affiliated institute of the University of Ottawa, closely associated with the university’s Faculties of Medicine and Health Sciences. OHRI includes more than 1,700 scientists, clinical investigators, graduate students, postdoctoral fellows and staff conducting research to improve the understanding, prevention, diagnosis and treatment of human disease.

Media contact
Paddy Moore
Communications and Public Relations
Ottawa Hospital Research Institute
613-737-8899 x73687
613-323-5680 (cell)